Product image of Ophtha-Cur (Timolol Maleate, Latanoprost) supplied by GNH India

Ophtha-Cur

Active Ingredient:
Timolol Maleate, Latanoprost
Origin:
EU

Ophtha-Cur (Timolol Maleate, Latanoprost)

Timolol maleate, the active ingredient in Ophtha-Cur, is a beta‑blocker presented as a ophthalmic solution for topical eye use. It lowers intra‑ocular pressure and is used in the management of glaucoma and ocular hypertension in adults. GNH India supplies Ophtha-Cur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH India supplies Ophtha-Cur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ophtha-Cur combines timolol maleate and latanoprost to treat conditions affecting ocular pressure regulation.

  • Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression.
  • Ocular hypertension: lowers eye pressure to prevent conversion to glaucoma.
  • Post‑surgical ocular pressure control: maintains target pressure after glaucoma surgery.

How It Works

  • Timolol maleate blocks beta‑adrenergic receptors in the ciliary body, decreasing aqueous humor production, while latanoprost, a prostaglandin F2α analogue, increases uve‑uvea outflow by remodeling the extracellular matrix of the ocular tissues. The combined actions result in a net reduction of intra‑ocular pressure.

Side Effects

Adverse reactions may occur with any ophthalmic medication and should be monitored.

Common Side Effects

  • Eye irritation
  • Burning sensation
  • Redness
  • Blurred vision
  • Dry eye
  • Foreign body sensation

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis)
  • Persistent eye pain
  • Significant vision loss
  • Corneal ulceration
  • Irregular pupil (anisocoria)
  • Rapidly worsening intra‑ocular pressure

Precautions & Warnings

When using Ophthalmic solutions  

  • Conduct  
  • Evaluate  r

-   t   t   ef   ewline   ewline   ewline   ewline -   ewline -  ewline   ewline -  lank  ewline -  ewline  ewline   -  ewline  """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" -  """ """"""""""""""""""""""""""""""""""""""""""""""""""""""""

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Timolol Maleate, Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT